These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
85 related items for PubMed ID: 19174319
1. Safety issues of adjunctive clopidogrel in patients discharged after percutaneous coronary intervention with stent placement and requiring oral anticoagulation. Guasch E, Sionis A, Reverter JC, Andrea R, Loma-Osorio P, Freixa X, Heras M. Int J Cardiol; 2011 Jan 07; 146(1):e1-4. PubMed ID: 19174319 [Abstract] [Full Text] [Related]
5. Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience. Maegdefessel L, Schlitt A, Faerber J, Bond SP, Messow CM, Buerke M, Raaz U, Werdan K, Muenzel T, Weiss C. Med Klin (Munich); 2008 Sep 15; 103(9):628-32. PubMed ID: 18813885 [Abstract] [Full Text] [Related]
6. Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding. Khurram Z, Chou E, Minutello R, Bergman G, Parikh M, Naidu S, Wong SC, Hong MK. J Invasive Cardiol; 2006 Apr 15; 18(4):162-4. PubMed ID: 16729401 [Abstract] [Full Text] [Related]
9. Meta-analysis of the combination of warfarin and dual antiplatelet therapy after coronary stenting in patients with indications for chronic oral anticoagulation. Gao F, Zhou YJ, Wang ZJ, Yang SW, Nie B, Liu XL, Jia de A, Yan ZX. Int J Cardiol; 2011 Apr 01; 148(1):96-101. PubMed ID: 21185095 [Abstract] [Full Text] [Related]
10. Design and rationale of the WOEST trial: What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing (WOEST). Dewilde W, Berg JT. Am Heart J; 2009 Nov 01; 158(5):713-8. PubMed ID: 19853687 [Abstract] [Full Text] [Related]
12. Efficacy of modified dual antiplatelet therapy combined with warfarin following percutaneous coronary intervention with drug-eluting stents. Baber U, Akhter M, Kothari S, Sharma SK, Kini A. J Invasive Cardiol; 2010 Feb 01; 22(2):80-3. PubMed ID: 20124594 [Abstract] [Full Text] [Related]
13. Clopidogrel for prevention of major cardiac events after coronary stent implantation: 30-day and 6-month results in patients with smaller stents. Calver AL, Blows LJ, Harmer S, Dawkins KD, Gray HH, Morgan JH, Simpson IA. Am Heart J; 2000 Sep 01; 140(3):483-91. PubMed ID: 10966552 [Abstract] [Full Text] [Related]
15. Safety of drug eluting stents in patients on chronic anticoagulation using long-term single antiplatelet treatment with clopidogrel. Pasceri V, Patti G, Pristipino C, Pelliccia F, Irini D, Varveri A, Roncella A, Di Sciascio G, Speciale G. Catheter Cardiovasc Interv; 2010 May 01; 75(6):936-42. PubMed ID: 20146326 [Abstract] [Full Text] [Related]
18. Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation. Helft G, Gilard M, Le Feuvre C, Zaman AG. Nat Clin Pract Cardiovasc Med; 2006 Dec 01; 3(12):673-80. PubMed ID: 17122800 [Abstract] [Full Text] [Related]